IRIS
PEDICA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.443
AS - Asia 2.166
NA - Nord America 1.424
SA - Sud America 369
AF - Africa 47
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.454
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.398
US - Stati Uniti d'America 1.323
SG - Singapore 895
CN - Cina 655
IT - Italia 434
BR - Brasile 300
HK - Hong Kong 222
VN - Vietnam 173
DE - Germania 127
FR - Francia 111
GB - Regno Unito 82
FI - Finlandia 62
CA - Canada 55
SE - Svezia 55
IN - India 54
NL - Olanda 39
MX - Messico 36
BD - Bangladesh 34
PL - Polonia 32
AT - Austria 31
AR - Argentina 26
JP - Giappone 23
TR - Turchia 17
IQ - Iraq 15
ES - Italia 14
ZA - Sudafrica 14
EC - Ecuador 11
IE - Irlanda 10
LT - Lituania 9
PK - Pakistan 9
ID - Indonesia 8
UZ - Uzbekistan 8
BE - Belgio 7
CH - Svizzera 7
VE - Venezuela 7
MA - Marocco 6
PY - Paraguay 6
DZ - Algeria 5
KE - Kenya 5
TH - Thailandia 5
TN - Tunisia 5
TW - Taiwan 5
UA - Ucraina 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AO - Angola 4
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
JM - Giamaica 4
PE - Perù 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
AU - Australia 3
GH - Ghana 3
IR - Iran 3
KR - Corea 3
MY - Malesia 3
PH - Filippine 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
IL - Israele 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
JO - Giordania 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
PT - Portogallo 1
RW - Ruanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.454
Salva come PNG Salva come JPEG
Città #
Singapore 588
Moscow 263
Ashburn 238
Hong Kong 215
San Jose 185
Dallas 147
Milan 125
Shanghai 123
Beijing 116
Hefei 81
Lauterbourg 71
Ho Chi Minh City 60
Los Angeles 60
New York 59
Boardman 43
Santa Clara 37
Munich 36
Hanoi 35
Rome 35
Council Bluffs 33
Orem 29
São Paulo 29
Warsaw 28
Helsinki 27
Nuremberg 26
London 25
Lappeenranta 22
Montreal 22
Frankfurt am Main 20
Tokyo 19
Vienna 19
Brooklyn 18
Guangzhou 17
Denver 16
Toronto 16
Chennai 15
Mexico City 15
Houston 13
Turku 13
Chicago 12
Johannesburg 12
Stockholm 12
Amsterdam 11
Ankara 11
Atlanta 11
Falkenstein 11
Lawrence 11
Poplar 11
Princeton 11
Romagnano Sesia 11
Seattle 11
Boston 10
Cesano Boscone 9
Da Nang 9
Dublin 9
San Francisco 9
Baghdad 8
Belo Horizonte 8
Genoa 8
Tashkent 8
Bexley 7
Brussels 7
Haiphong 7
Mugnano di Napoli 7
Phoenix 7
Shenzhen 7
Trento 7
Xi'an 7
Bergamo 6
Bologna 6
Cagliari 6
Guarulhos 6
Jiaxing 6
Manchester 6
Monza 6
Paris 6
Parma 6
Rio de Janeiro 6
City of London 5
Dhaka 5
Gatchina 5
Mumbai 5
Nairobi 5
New Delhi 5
Ottawa 5
Philadelphia 5
Porto Alegre 5
Rho 5
Asunción 4
Barnet 4
Casablanca 4
Charlotte 4
Copenhagen 4
Hyderabad 4
Jakarta 4
Khon Kaen 4
Kingston 4
Montevideo 4
Ninh Bình 4
Pune 4
Totale 3.366
Salva come PNG Salva come JPEG
Nome #
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 183
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 171
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger? 164
Pathology and molecular pathology of cholangiocarcinoma 133
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging 123
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 122
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib 117
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 115
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 113
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 103
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 103
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 103
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 102
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 102
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 102
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 101
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 101
Association of IgG4-related disease and systemic rheumatic disorders 99
Gene-Based Immune Reprogramming Overcomes the Immunosuppressive Microenvironment of Liver Metastases and Enables Protective T Cell Responses 98
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 97
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 96
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 95
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 93
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome 93
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse 92
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 91
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 90
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions 88
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 87
Cholangiocarcinoma: new perspectives for new horizons 87
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 87
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 87
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 85
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies 84
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime 83
The real life of precision medicine in biliary tract cancers: a tertiary referral centre experience 83
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos 82
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 80
Subcutaneous dirofilariosis in Italy: a diagnostic hypothesis to remind when the anamnesis is misleading 79
Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA) 79
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 78
HCC in metabolic syndrome: current concepts and future directions 77
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming 77
The oncologic burden of residual disease in incidental gallbladder cancer: An elastic net regression model to profile high-risk features 75
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 74
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations 73
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] 72
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure 71
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 71
Repeated administration of the food additive E171 to mice results in accumulation in intestine and liver and promotes an inflammatory status 70
Clinicopathological features of adenosquamous pancreatic cancer 68
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 68
Late Breaking Abstract - Morphological and immunophenotypical features of lung tissue in early phase of COVID-19 66
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report 65
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease 64
Pure and mixed gallbladder neuroendocrine neoplasms: rare and orphan lesions 63
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 62
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 61
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination 61
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. 59
PDX-1 (Pancreatic/Duodenal Homeobox-1 Protein 1) 58
Hydroxyapatite/collagen composite is a reliable material for malar augmentation 57
Mucinous cystic neoplasms of the liver: A clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct 56
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 55
Lymphangiogenesis in Crohn's disease: An immunohistochemical study using monoclonal antibody D2-40 54
Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease 54
Total portal vein replacement with peritoneal interposition graft during Whipple’s procedure for extrahepatic cholangiocarcinoma: a technical report 53
Endocrine neoplasms of the pancreas: pathologic and genetic features. 53
Heterogeneity of response and immune system activity during treatment with nivolumab in hepatocellular carcinoma: Results from a single-institution retrospective analysis 53
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 52
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 52
Programmed death 1 (PD-1) and its ligand (PD-L1) as a new frontier in cancer Immunotherapy and challenges for the Pathologist: State of the art 50
IgG4-related autoimmune liver disease 49
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 49
Paraoxonase-1 status in patients with hereditary hemochromatosis 48
Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma 47
Massive retinal gliosis in a young woman with congenital toxoplasmosis 47
Preliminary results of the influence of the in vivo use of a lymphatic dye (Patent Blue V) in the surgical treatment of Crohn's disease 46
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 45
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes 44
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? 40
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: A case report and review of the literature 40
Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines 37
Next-generation histopathologic diagnosis: A lesson from a hepatic carcinosarcoma 35
A viable human lung cancer tissue collection (LCTC) to accelerate translational research 5
How to approach indeterminate biliary stenosis 2
Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature 1
Totale 6.650
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.308
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 2 3 0 2 2 1 1 2 0 1
2022/202382 25 16 9 0 1 15 5 4 7 0 0 0
2023/2024449 11 65 50 41 20 33 19 42 4 18 64 82
2024/20251.506 169 41 63 69 85 117 260 177 170 86 112 157
2025/20264.592 355 306 217 620 601 181 446 383 1.293 190 0 0
Totale 6.650